Covered recipient · General Payments record
GRACE SONG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$642.34
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $140.47 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $58.23 | 3 |
| Currax Pharmaceuticals LLC | $29.20 | 2 |
| Astellas Pharma US Inc | $23.66 | 1 |
| Abbott Laboratories | $14.83 | 1 |
| Lilly USA, LLC | $14.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.83 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125326288 | CMS |
| Astellas Pharma US Inc | $23.66 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139325854 | CMS |
| Currax Pharmaceuticals LLC | $15.95 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089511034 | CMS |
| Currax Pharmaceuticals LLC | $13.25 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089511036 | CMS |
| Lilly USA, LLC | $14.55 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012389 | CMS |
| Novo Nordisk Inc | $18.50 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097313737 | CMS |
| Novo Nordisk Inc | $21.62 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097179293 | CMS |
| Novo Nordisk Inc | $18.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097837655 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.